chloramphenicol has been researched along with benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Chan, LC; Holt, DE; Kong, CT; Lie, AK; Ma, SK | 1 |
2 other study(ies) available for chloramphenicol and benzyloxycarbonylvalyl-alanyl-aspartyl fluoromethyl ketone
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
Effects of antioxidants and a caspase inhibitor on chloramphenicol-induced toxicity of human bone marrow and HL-60 cells.
Topics: Amino Acid Chloromethyl Ketones; Anti-Bacterial Agents; Antigens, CD34; Antioxidants; Apoptosis; Bone Marrow Cells; Caspase Inhibitors; Cell Cycle; Chloramphenicol; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Erythroid Precursor Cells; HL-60 Cells; Humans | 2000 |